Skip to main content
IMUX
NASDAQ Life Sciences

Immunic Secures Operations into Late 2027 with $200M Private Placement Despite Widened Q1 Loss

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$12
Mkt Cap
$162.096M
52W Low
$5.062
52W High
$15.1
52W Position info
137% above low
Off High info
21% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

IMUX has more than doubled off its 52-week low of $5.062 on light trading volume (0.4× avg).

Summary

Immunic reported a widened Q1 net loss of $32.6 million, or $1.08 per share, primarily driven by increased R&D and general and administrative expenses. However, the company also announced a significant $200 million private placement, which boosted its cash position to $186.6 million. This substantial capital infusion is expected to fund operations into late 2027, providing a critical financial runway for the clinical-stage biotech. This news precedes the official 10-Q filing later today, offering an early look at the company's Q1 performance and strategic financing. While the widening loss is a negative, the secured funding significantly de-risks the company's near-term financial outlook and ability to advance its drug development programs.

At the time of this announcement, IMUX was trading at $12.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $162.1M. The 52-week trading range was $5.06 to $15.10. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IMUX - Latest Insights

IMUX
Nov 13, 2026, 7:12 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.71
Real-time Price: $7.25 info
Change: -$0.460 (-6%) info
Market Cap: $117.359M info
IMUX
Nov 05, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.20
Real-time Price: $7.25 info
Change: -$0.950 (-12%) info
Market Cap: $117.359M info
IMUX
Sep 09, 2026, 9:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.26
Real-time Price: $7.25 info
Change: -$6.01 (-45%) info
Market Cap: $117.359M info
IMUX
Aug 11, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.10
Real-time Price: $7.25 info
Change: -$6.85 (-49%) info
Market Cap: $117.359M info
IMUX
Aug 11, 2026, 6:59 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.10
Real-time Price: $7.25 info
Change: -$6.85 (-49%) info
Market Cap: $117.359M info